Related Experiment Video
Updated: Jun 12, 2026
05:00
Multiplex Immunohistochemistry Staining for Paraffin-embedded Lung Cancer Tissue
Published on: November 21, 2023
Quantitative immunohistochemistry in lung cancer: clinical perspective
Ewa Szutowicz1, Rafał Dziadziuszko
1Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
Folia Histochemica Et Cytobiologica
|June 10, 2010
Abstract:
Quantitative immunohistochemistry remains an important tool in translational lung cancer research with hopes to improve patient outcomes and avoid unnecessary therapies. Present review is aimed to summarize the use of immunohistochemical markers for improved prognostic information and prediction of treatment benefit. Several of these markers are currently explored in phase II-III clinical studies to individualize the treatment of lung cancer.
